The catalysts for a major biotech rally in 2017 are already multiplying—not least because of the Trump presidential victory—and one little-known company is poised for huge potential gains as it prepares to unveil a breakthrough medical device that could save the U.S. government tens of billions of dollars a year, and help prevent the 15 …View the full post at: Amgen (AMGN) – This Could Be The Biggest Winner Of 2017’s Biotech Boom …
Related Articles:
Alphabet (GOOGL) Goes Harder After Mobile
Alphabet (GOOGL) Looks Good But Has Risk
